Effect of the Prebiotic Oligofructose on Relapse of Clostridium difficile-Associated Diarrhea: A Randomized, Controlled Study Stephen Lewis, Stephen Burmeister, Jon Brazier Clinical Gastroenterology and Hepatology Volume 3, Issue 5, Pages 442-448 (May 2005) DOI: 10.1016/S1542-3565(04)00677-9 Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 1 Change in fecal bacterial concentration in each study period for those patients taking oligofructose (n = 16) and those taking placebo (n = 14). Clinical Gastroenterology and Hepatology 2005 3, 442-448DOI: (10.1016/S1542-3565(04)00677-9) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 2 Kaplan-Meier survival estimates (recurrence of diarrhea) for those receiving oligofructose or placebo supplements. Clinical Gastroenterology and Hepatology 2005 3, 442-448DOI: (10.1016/S1542-3565(04)00677-9) Copyright © 2005 American Gastroenterological Association Terms and Conditions